1 References 1. Bainbridge D, Martin J, Arango M, Cheng D. Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. The Lancet. 2012; 380: 1075–1081 doi: 10.1016/s0140-6736(12)60990-8. 2. Nagrebetsky A, Gabriel RA, Dutton RP, Urman RD. Growth of Nonoperating Room Anesthesia Care in the United States: A Contemporary Trends Analysis. Anesthesia & Analgesia. 2017; 124: 1261–1267 doi: 10.1213/ane.0000000000001734. 3. Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. Use of Psychedelics for Pain: A Scoping Review. Anesthesiology. 2023; 139: 523–536 doi: 10.1097/aln.0000000000004673. 4. Anand A et al. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. New England Journal of Medicine. 2023; 388: 2315–2325 doi: 10.1056/nejmoa2302399. 5. Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, Holt C von, Young AH, Godinov Y. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. New England Journal of Medicine. 2023; 389: 1298–1309 doi: 10.1056/nejmoa2304145. 6. Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuellar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. The Lancet. 2022; 399: 555–604 doi: 10.1016/S0140-6736(21)02252-2. 9
RkJQdWJsaXNoZXIy MTk4NDMw